Advertisement

Topics

Merck's Antiviral Drugs Meets Main Goal in Late-Stage Trial

12:30 EDT 19 Oct 2016 | Drug Discovery Development

Merck & Co Inc said its experimental drug to prevent cytomegalovirus infection in high-risk bone marrow transplant patients met its primary goal in a late-stage trial.
Contributed Author: 
Shailesh Kuber, Reuters
Topics: 

Original Article: Merck's Antiviral Drugs Meets Main Goal in Late-Stage Trial

NEXT ARTICLE

More From BioPortfolio on "Merck's Antiviral Drugs Meets Main Goal in Late-Stage Trial"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...